SCYNEXIS (SCYX)

[GMA13]

IMO but not to Advise:
The reverse stock split seems to be a very good idea based on the following reasons, especially given SCYX’s very anemic share price.

• SCYX’s niche science to date has proven very good results for treating difficult conditions. This typically can bode well for a future robust investment once FDA approval is finalized.

• Reverse stock splits increase the share price to avoid delisting, and to meet the threshold required for listing on a major exchange. This is important for attracting equity investors especially institutional types. A reverse split might also be done to boost the company's image if the stock price has dropped dramatically. All of these typical reasons may apply to SCYX!

• SCYX’s anemic share price is seemingly the direct result of toxic financing e.g. the 1-for-1 for Ordinary Shares (@ $.90) + Options (& $1.10). There has been continuous massive selling & possibly rebuying which has suppressed the share price throughout the delivery of periodic good news.